Treatment of pancreatic disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/275 (2006.01) A61P 1/18 (2006.01)

Patent

CA 2382529

The present invention relates to the administration of cyanohydroxybutene (CHB) to eliminate acinar cells in a subject. Subcutaneous injection of CHB at a sub-lethal dosage caused apoptosis of the substantially entire population of acinar cells. The pancreatic lesion has marked early edema with limited inflammatory infiltration, rapid synchronous onset of acinar cell apoptosis and advanced atrophy with a severely limited regenerative response. There is further provided methods of treatment of acinar cell carcinoma and pancreatitis.

La présente invention concerne une administration de cyanohydroxybutène (CHB) permettant d'éliminer les cellules acineuses d'un sujet. L'injection d'une dose sublétale de CHB provoque l'apoptose quasi générale d'une population de cellules acineuses. Une lésion pancréatique peut se manifester par un oedème précoce avec une infiltration inflammatoire limitée, un départ synchrone rapide de l'apoptose des cellules acineuses et une atrophie avancée avec une réponse régénérative limitée. L'invention concerne également des méthodes de traitement de carcinomes des cellules acineuses et de pancréatites.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of pancreatic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of pancreatic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of pancreatic disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1725715

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.